Combined CDC COVID-19/Influenza Test Amended to Include Promega Maxwell® RSC 48 and CSC 48 Instruments, Maxwell® RSC Viral Total Nucleic Acid Purification Kit
on January 14 2021 1:00 AM
Expanded list of authorized instruments and reagents allows more options for labs running CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay
MADISON, Wis.--(BUSINESS WIRE)--#COVID19--Labs performing the Centers for Disease Control’s (CDC) Flu SC2 Multiplex Assay, a single test to diagnose infection caused by SARS-CoV-2, influenza A, or influenza B, can now use two Promega instruments and a Promega nucleic acid purification kit in the protocol. In a letter dated January 8, 2021, the US Food and Drug Administration (FDA) authorized an amendment to the Emergency Use Authorization (EUA) for the CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay that adds the Maxwell® RSC 48 and Maxwell® CSC 48 instruments, along with the Maxwell® RSC Viral Total Nucleic Acid Purification Kit, as options for the test procedure.